Norwich Eaton Pharmaceuticals, Inc.

Morton-norwich Products, Inc.

Allan V Bayless

Ozra E Millner, Jr

Thomas J Moorehead

Stanford S Pelosi, Jr

Chau-Ting Huang

The present invention involves certain N-hydroxy-5-phenyl-2-furancarboximidamides, pharmaceutical compositions containing such compounds, and methods for increasing the contractile force of cardiac muscle of a mammal which comprises systemically administering such compounds to a mammal.

N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents

The present invention involves compounds of the class of acylphosphorotriamides and methods for altering the blood plasma lipid content of mammals which comprises systemically administering to mammals an effective but nontoxic amount of a composition comprising such compounds.

Acylphosphorotriamides useful as lipid-altering agents

Certain phosphorotriamides of the formula ##STR1## wherein R is hydrogen, phenyl, 4-nitrophenyl, 4-aminophenyl, 4-cyanophenyl or 3-trifluromethylphenyl are useful as inhibitors of the enzyme urease.

Phosphorotriamides as urease inhibitors

A series of N-[diaminophosphinyl]arylcarboxamides are useful as inhibitors of the enzyme urease.

Growing community of inventors

Norwich, NY, United States of America

Allan V Bayless